Insider holders · CIK 0001472012
Immunome Inc. · IMNM
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Clay B SiegallPresident and CEO | 870,704 | — | 870,704 | Jul 27, 2026 · 4:10 pm EDT | Form 4 |
| Max RosettChief Financial Officer | 101,287 | — | 101,287 | Jul 27, 2026 · 4:10 pm EDT | Form 4 |
| Isaac BarchasDirector | 92,211 | 0 | 92,211 | Aug 12, 2026 · 5:47 pm EDT | Form 4 |
| Philip TsaiChief Technical Officer | 81,550 | — | 81,550 | Jul 27, 2026 · 4:10 pm EDT | Form 4 |
| Robert LechleiderChief Medical Officer | 69,805 | — | 69,805 | Jul 27, 2026 · 4:10 pm EDT | Form 4 |
| Jack HigginsChief Scientific Officer | 56,250 | 1,000 | 57,250 | Sep 15, 2026 · 4:30 pm EDT | Form 4 |
| Sandra G. StonemanCHIEF LEGAL OFFICER & GC | 43,805 | — | 43,805 | Jul 27, 2026 · 4:10 pm EDT | Form 4 |
| Jean Jacques BienaimeDirector | 43,415 | — | 43,415 | Jun 9, 2026 · 5:40 pm EDT | Form 4 |
| Kinney HornCHIEF BUSINESS OFFICER | 0 | — | 0 | Aug 6, 2026 · 6:30 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.